Addition of astragalus into peritoneal dialysate improve peritoneal macrophages function in CAPD patients
- VernacularTitle:腹膜透析液中添加黄芪对腹腔巨噬细胞功能的影响
- Author:
Chunming JIANG
;
Miao ZHANG
;
Zheng SUN
- Publication Type:Journal Article
- Keywords:
Astragalus;
Peritoneal dialysis;
Macrophages
- From:
Journal of Medical Postgraduates
2004;0(02):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the effect of Astragalus on peritoneal macrophages function in stable continuous ambulatory peritoneal dialysis(CAPD) patients. Methods: 28 stable CAPD patients were included in this study.All the patients were treated with peritoneal dialysis fluid containing Astragalus(20 ml/2 L) in vivo for one week.Peritoneal macrophages function such as phagocytosis ratio、bactericidal ratio、excretion of cytokines(TNF-? and NO) and mitochondrial dehydrogenases activity(MTT assay) were examined ex vivo just before and after the treatment. In vitro,peritoneal macrophages isolated from effluent were incubated with RPMI 1640、CDF or CDF containing various concentrations of Astragalus. Then peritoneal macrophages function mentioned above were examined again and compared. Results:No significant difference was found in TNF-? level in effluent between before and after the treatment (100?63)ng/L vs (116?60)ng/L, (P=0.192). While comparing with pre-treatment, peritoneal macrophages function was improved significantly after the addition of Astragalus into dialysate (phagocytosis ratio: (34.8?12.7)% vs (43.4?9.3)%,P0.05).The results in these two groups were significantly lower than those in Astragalus groups(P0.05). While significant decreasing in NO level and mitochondrial dehydrogenases activity were observed in 8% Astragalus groups as compared with those in 2% Astragalus group(P
